The IPKat

All to play for in CRISPR "first-to-invent" US patent battle as Federal Circuit instructs PTAB to reconsider (Regents v. Broad Institute, Nos. 22-1594, 22-1653)

EU moves one step closer to gene editing regulation

Tuesday Wonders

[Guest post] Dramatic reversal in the CRISPR Broad Institute cases following G 1/22

European Parliament votes to exclude gene edited plants from patentability

Is the Broad Institute planning a last-ditch attempt to save their CRISPR patent?

Aftermath of the CRISPR hearing - Highlights from the blogosphere

CRISPR hearing Day 4: Still a clear cut case of invalid priority, Broad Institute's appeal dismissed

CRISPR hearing days 2-3: Board of Appeal poised to refer to the EBA?

The Broad Institute's CRISPR patent appeal hearing: Day 1, Setting the Stage